Both in Pharmaceuticals
Mereo BioPharma Group vs Bicycle Therapeutics
Over the past year MREO returned −83.2% and BCYC returned −43.9%; their daily moves had a correlation of 0.09.
MREO −83.2% BCYC −43.9%Growth of $1, one year, split-adjusted
| Metric | MREO | BCYC |
|---|---|---|
| Price | $0.2979 | $3.69 |
| Market cap | $47.6M | $258.6M |
| Today | +0.95% | −2.12% |
| 1 month | −5.5% | −2.9% |
| 6 months | +21.1% | −21.8% |
| Year to date | −28.5% | −47.9% |
| 1 year | −83.5% | −42.7% |
| Revenue growth (YoY) | — | +190.2% |
| Gross margin | — | 100.0% |
| Net margin | — | −30.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.1× |
| Net cash | — | $469.9M |
| Dividend yield | — | — |
| Volatility (60d) | 78.8% | 57.2% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).